News
29m
Asianet Newsable on MSNGSK’s Blenrep Underwhelms FDA Panel Over Dose Risk-Benefit Balance In Myeloma; Retail Traders Stay OptimisticThe median progression-free survival was 32.6 months on the Blenrep combo compared to 12.5 months on the alternative. While ...
The FDA said Juul's benefits as a less harmful alternative for adult smokers outweigh the risks of teen use. Darius Rucker ...
It's a major win for a company that has struggled for years after being widely blamed for sparking the teen vaping trend.
The Food and Drug Administration uses import alerts to enforce U.S. food safety regulations for food from foreign countries. The agency updates and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results